We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$208M
AUM Growth
+$48.7M
Cap. Flow
+$39M
Cap. Flow %
18.74%
Top 10 Hldgs %
22.47%
Holding
889
New
716
Increased
102
Reduced
57
Closed

Sector Composition

Rank Sector Weight
1 Technology 11.36%
2 Healthcare 8.65%
3 Industrials 7.48%
4 Consumer Staples 7%
5 Communication Services 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSI icon
676
iShares MSCI KLD 400 Social ETF
DSI
$5.54B
$8K ﹤0.01%
+150
New +$7.9K
EDIT icon
677
Editas Medicine
EDIT
$442M
$8K ﹤0.01%
+251
New +$8.11K
MEDP icon
678
Medpace
MEDP
$16.5B
$8K ﹤0.01%
+141
New +$7.71K
NGNE icon
679
Neurogene
NGNE
$712M
$8K ﹤0.01%
+131
New +$7.73K
OLN icon
680
Olin
OLN
$2.12B
$8K ﹤0.01%
+311
New +$9.13K
IFLN
681
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$8K ﹤0.01%
+440
New +$8.14K
RSP icon
682
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$8K ﹤0.01%
+72
New +$7.61K
SMG icon
683
ScottsMiracle-Gro
SMG
$3.66B
$8K ﹤0.01%
+100
New +$7.86K
SPLV icon
684
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
$8K ﹤0.01%
+154
New +$7.57K
VVV icon
685
Valvoline
VVV
$4.51B
$8K ﹤0.01%
+378
New +$8.21K
VWO icon
686
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$8K ﹤0.01%
+200
New +$8.41K
XOMA
687
DELISTED
Xoma
XOMA
$8K ﹤0.01%
+447
New +$8.96K
CSCI
688
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$8K ﹤0.01%
+44
New +$8.07K
PVLA
689
Palvella Therapeutics
PVLA
$2.27B
$8K ﹤0.01%
+19
New +$8.26K
MRO
690
DELISTED
Marathon Oil Corporation
MRO
$8K ﹤0.01%
+364
New +$7.62K
ARQL
691
DELISTED
Arqule Inc
ARQL
$8K ﹤0.01%
+1,362
New +$7.75K
ARRY
692
DELISTED
Array Biopharma Inc
ARRY
$8K ﹤0.01%
+548
New +$8.4K
ABEO icon
693
Abeona Therapeutics
ABEO
$413M
$7K ﹤0.01%
+22
New +$7.8K
CDP icon
694
COPT Defense Properties
CDP
$4.21B
$7K ﹤0.01%
+250
New +$7.49K
COLL icon
695
Collegium Pharmaceutical
COLL
$956M
$7K ﹤0.01%
+466
New +$8.26K
DINO icon
696
HF Sinclair
DINO
$14.5B
$7K ﹤0.01%
+101
New +$7.13K
FHI icon
697
Federated Hermes
FHI
$4.72B
$7K ﹤0.01%
+300
New +$7.05K
HWM icon
698
Howmet Aerospace
HWM
$112B
$7K ﹤0.01%
+393
New +$6.25K
IAK icon
699
iShares US Insurance ETF
IAK
$548M
$7K ﹤0.01%
+100
New +$6.52K
IEZ icon
700
iShares US Oil Equipment & Services ETF
IEZ
$364M
$7K ﹤0.01%
+185
New +$6.57K

Similar funds

Truvestments Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Truvestments Capital held 889 positions worth $208M, up 31% from $159M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Truvestments Capital deployed $39M of net new capital in Q3 2018, opening 716 new positions and adding to 102 existing holdings. Its largest new stake was Invesco Variable Rate Preferred ETF: 50,026 shares worth $1.25M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.7% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Financials ETF, an estimated $917K trimmed.

  • Truvestments Capital's largest Q3 2018 buy was Invesco Variable Rate Preferred ETF: 50,026 shares worth $1.25M.
  • Truvestments Capital added most to Amazon in Q3 2018, an estimated $985K increase.
  • Truvestments Capital's biggest Q3 2018 reduction was Vanguard Financials ETF, cutting an estimated $917K.
  • Truvestments Capital's ten largest holdings make up 22% of its $208M portfolio in Q3 2018.
  • Truvestments Capital opened 716 new positions and closed 0 in Q3 2018.
  • Truvestments Capital's portfolio value rose 31% quarter-over-quarter to $208M.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.